Athos Therapeutics Inc’s Post

Cancer. Sounds scary. I studied cancer research for my undergrad at UCLA with a goal in mind to help us eradicate it and manage it to bring us to a healthier place for all humans. Little did I know then, or even 2 years ago, that I would come back to that. Now, I am working with the RIGHT kind of docs - not Big pHarma, but with renowned, incredibly well-respected Doctors that understand that this is nature's WAKE UP CALL! And it's the body's most desperate cry for POSITIVE CHANGE as it tries to HEAL. And the good news is that IT CAN! I'm THRILLED that this year's theme for the #HealingfortheAGES Annual Fall Conference is "Cleansing the Causes of Cancer." If you or a loved one has #cancer, join us. If you're concerned about the growing RATE of cancer, join us. If you want to focus on prevention, join us. If you need help getting through it, or with #chemotherapy, join us. The new promotional trailer for the conference is just published. Check it out! Join us virtually, and save $50, using coupon code "AGES". This may save your life or the life of a family member. The #masterclass is FREE, open to the public! September 12 - 14, 2024 in Dallas, TX. I'll be there, managing the #conference, also GLUED to the content! Subscribe on Rumble to HealingfortheAGES, and follow the brilliant work of Drs. Bryan Ardis, Dr. Edward Group, Dr. Henry Ealy, & Dr. Jana Schmidt, plus countless other experts in the natural sciences. #wecanheal #naturalremedies #naturewins Dr. Edward Group III, DC Energetic Health Institute #wellness #naturopathicmedicine #conference #Healing https://lnkd.in/gbH9JXgt.

Interesting reflection by Noah Smith concerning the balance between progress and the depth of human experience by exploring the idea that as we conquer adversities our lives become safer, but perhaps shallower. https://lnkd.in/dg7UnbTX

📣 Watch This Eye-Opening Video on Rare and GI Cancers 📣 Have you noticed the alarming rise in cancer diagnoses, especially rare and GI cancers? It's a growing issue that's often overlooked, but it needs our attention now more than ever. 🧠 My Observations: Rising Mortality Rates: Rare and GI cancers are on an alarming rising trend and they are deadly, with higher mortality rates while more commonly diagnosed, Breast and Prostate cancers which have higher diagnoses but also very high success rates. Survival Rate Goals: Cancer Australia's 2030 goal of an 80% five-year survival rate is currently languishing at 70% (for over a decade) and at risk of falling due to there disproportionate lethality and rise in diagnoses. The Future of Cancer: Empower the Patient – Increase Survival: Empower their entire support community – Exponentially Increase Survival. This approach isn't just common sense; it's a solution hidden in plain sight. The Empowered Patient stands uniquely positioned and equipped to understand, engage, and ultimately succeed. They hold the power to influence and reshape both science and healthcare, leading to increased survivorship and reducing financial burdens both privately and publicly. This strategy bridges the critical gap between the success of early detection and the dire statistics associated with late-stage diagnoses. 👉 Watch the video now: https://lnkd.in/gB8ZMshS RealityCheck HEALTHY PEOPLE GET CANCER TOO; We are all healthy until we are not. None of us can predict when we might face a cancer diagnosis. Even healthy individuals, including doctors, nurses, and scientists, are not immune. That’s why being well-equipped with knowledge and resources becomes a crucial factor and advantage if we are ever unexpectedly diagnosed with a serious cancer. Let's wake more people up and make a difference! ✨ Kind Regards Steve Holmes Omico #CancerAwareness #EmpoweredPatients #RareCancer #GICancer #CancerSurvival #cholangiocarcinoma #Cholnagio #CholangioChallengers #rarecancers

🔬🌍 Major Advance in Kidney Cancer Diagnosis! 🌍🔬   We’re excited to share a breakthrough in kidney cancer detection developed right here in Victoria! With over 4,500 Australians diagnosed each year, Zircaix - an innovative imaging tool by Telix Pharmaceuticals Limited - is set to transform diagnosis and treatment worldwide.   Zircaix combines an antibody with a radioactive probe to target a protein produced by kidney cancer cells, allowing precise tumour detection on scans. In a multinational phase three study with 300 patients, it proved to be a game-changer, offering a non-invasive alternative to biopsies, and reducing unnecessary surgeries.   Our very own Prof. Andrew Scott played a key role in these successful clinical trials which showcased the tool’s exceptional accuracy and safety. Published in The Lancet Oncology, the findings underscore Zircaix’s potential to improve patient outcomes globally.   Congratulations to Prof. Scott and the entire team involved in this remarkable achievement! 🎉👏   🔗 Learn more in today's Herald Sun. ____________________________________   #KidneyCancer #CancerResearch #ONJCRI #Innovation #MedicalImaging #ClinicalTrials #PrecisionMedicine #GlobalImpact

p53: A tale of complexity and context https://lnkd.in/daBnDTCq

Join us for our Great Debates and Updates meeting series covering both solid and liquid tumor topics throughout the year! Engage in thoughtful discussions with your peers to improve patient care and outcomes. Our meetings are a great opportunity to connect, learn and grow! Check out the dates for our meetings for the remainder of the year: - Great Debates & Updates Hematological Malignancies: April 5-6- NYC - Great Debates & Updates in Lung Cancer : April 27-28- NYC - Great Debates & Updates in Women's Oncology: May 3-4, NYC - Great Debates & Updates Hem/Myeloma Day: May 11 - Dallas - Great Debates & Updates in GI Malignancies: May 17-18 - NYC - Great Debates & Updates Hematological Malignancies: July 27 -28 - Los Angeles - Great Debates & Updates in Lung Cancer : October 5-6 - Dallas - Great Debates & Updates in GI Malignancies: October 19-20 - Dallas - Great Debates & Updates in Women's Oncology: November 1-2 - Nashville If you're interested in attending any of these meetings or need additional information regarding commercial sponsorships, let me know! #oncology #patientcare #healthcare #medicalconference #greatdebates&updates #GDU Great Debates & Updates

Viewpoint discusses the end point analyses and results of the RACICALS-RT study. https://ja.ma/3xJDi9s

A good discussion and action plan in this article to address this serious problem

It is time to address the elephant in the room! And to conduct a few more well-designed cost-effectiveness studies from a societal perspective. https://lnkd.in/d4n3PxGP

#LungCancer is one of the most expensive cancers when diagnosed at a late stage, costing tens of thousands more than early-stage treatment. In a recent New York Times letter to the editor, our #CEO, Laurie Ambrose, highlighted the crucial role of #EarlyDetection through lung cancer screening. As Laurie stated, "We need to invest more, not less, to find the disease early when it can be managed and cured...Screening saves lives." Read more about the importance of early detection and our ongoing work to promote lung cancer screening 👉🏻 https://nyti.ms/3SZ6P6j #LungCancerAwareness